world federation of hemophilia
play

WORLD FEDERATION OF HEMOPHILIA Mark Brooker, WFH Senior Public - PowerPoint PPT Presentation

WORLD FEDERATION OF HEMOPHILIA Mark Brooker, WFH Senior Public Policy Officer London July 2, 2015 PATIEN TS PER SPEC TIVE The World Federation of Hemophilia (WFH), an international not-for-profit organization, was established in 1963.


  1. WORLD FEDERATION OF HEMOPHILIA Mark Brooker, WFH Senior Public Policy Officer London – July 2, 2015

  2. PATIEN TS’ PER SPEC TIVE The World Federation of Hemophilia (WFH), an international not-for-profit organization, was established in 1963. It is a global network of patient organizations in 127 countries and has official recognition from the World Health Organization

  3. PATIEN TS’ PER SPEC TIVE Global significance of decisions made by FDA/EMA o Humanitarian aid o Product withdrawals/recalls o Indications o How products are used in different parts of the world

  4. ID EN TIFIED PATIEN TS – R EG ION 400,000 350,000 300,000 250,000 200,000 expected 150,000 identified 100,000 50,000 0

  5. IN C R EA SE IN FA C TO R U SE PER C A PITA 2.00 World FVIII use over time 1.91 1.76 1.75 1.51 1.46 1.50 1.45 1.41 FVIII IU per capita 1.35 1.32 1.31 1.26 1.25 1.22 1.25 1.01 1.00 0.97 1.00 0.95 0.95 0.92 0.89 0.84 0.80 0.73 0.75 0.64 0.56 0.54 0.53 0.50 0.25 0.07 0.07 0.06 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.00 ADDITIONAL TEXT EXAMPLE 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Lower income - less than $2000 Middle income- $2000-$10,000 World Source: REPORT ON THE ANNUAL GLOBAL SURVEY 2013

  6. PATIEN TS’ PER SPEC TIVE 2013 Global Survey: Reported data source • 107 countries reporting • Country registry: 31 • Registry of HTCs: 24

  7. PATIEN TS’ PER SPEC TIVE 55% of new cases – no family history or spontaneous mutation • Families with a history of hemophilia • Parents with no experience/knowledge of hemophilia

  8. PATIEN TS’ PER SPEC TIVE Transparency vs. data protection laws o WFH would like to see more post-marketing surveillance o Education on the importance of PMS o PUPs (and other patients) enrolled in clinical studies, not in registries? o Unique, anonymous identifier for all patients?

  9. TH AN K YOU

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend